330 results on '"Rayar Michel"'
Search Results
2. Comparing indications, complexity and outcomes of laparoscopic liver resection between centers with and without a liver transplant program: a French nationwide study
3. Correction: End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial—HOPExt
4. End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial—HOPExt
5. Liver transplantation and hepatocellular carcinoma: is TIPS deleterious? A multicentric retrospective study of the ARCHET research group with propensity score matching
6. Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study)
7. Adverse Events and Outcomes of High-volume Plasma Exchange in 50 Acute Liver Failure Patients: A Monocentric Retrospective Real-world Study
8. Understanding the Brain-based Determination of Death When Organ Recovery Is Performed With DCDD In Situ Normothermic Regional Perfusion
9. Comparing indications, complexity and outcomes of laparoscopic liver resection between centers with and without a liver transplant program: a French nationwide study
10. Drug transporters are implicated in the diffusion of tacrolimus into the T lymphocyte in kidney and liver transplant recipients: Genetic, mRNA, protein expression, and functionality
11. Prolonged preservation by hypothermic machine perfusion facilitates logistics in liver transplantation: A European observational cohort study
12. Therapeutic anticoagulation after liver transplantation is not useful among patients with pre‐transplant Yerdel‐grade I/II portal vein thrombosis: A two‐center retrospective study
13. Renoportal Anastomosis During Liver Transplantation in Patients With Portal Vein Thrombosis: First Long-term Results From a Multicenter Study
14. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients.
15. Inferior Vena Cava Leiomyosarcoma: What Method of Reconstruction for Which Type of Resection?
16. How to Handle Arterial Conduits in Liver Transplantation? Evidence From the First Multicenter Risk Analysis
17. Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients: The STABILE Study
18. Aspects chirurgicaux du prélèvement multiorganes en vue de greffes
19. The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation: A retrospective cohort study
20. How to Handle Arterial Conduits in Liver Transplantation? Evidence From the First Multicenter Risk Analysis
21. End-ischemic Hypothermic Oxygenated Perfusion for Extended Criteria Donors in Liver Transplantation – A multicenter, randomized controlled trial - HOPExt
22. Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4–7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal Function
23. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension
24. Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors
25. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation
26. A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients
27. Frey procedure combined with biliary diversion in chronic pancreatitis
28. Is systematic nasogastric decompression after pancreaticoduodenectomy really necessary?
29. Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study
30. Waitlist mortality of young patients with biliary atresia: Impact of allocation policy and living donor liver transplantation
31. Comparison of reconstruction methods used during liver transplantation in case of a graft with replaced or accessory right hepatic artery: A retrospective study
32. Preoperative bevacizumab and surgery for colorectal liver metastases: a propensity score analysis
33. Pancreatic head cancer in patients with chronic pancreatitis
34. Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results
35. High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes
36. Tacrolimus: Does direct glucuronidation matter? An analytical and pharmacological perspective
37. Comparison of reconstruction methods used during liver transplantation in case of a graft with replaced or accessory right hepatic artery: A retrospective study.
38. Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT)
39. Abdominal Pain due to a Wandering Liver
40. Disposable bipolar irrigated sealer (Aquamantys®) for liver resection: use with caution
41. Leiomyosarcoma of the inferior vena cava: Chasing the disease
42. Benefits of temporary portocaval shunt during orthotopic liver transplantation with vena cava preservation: A propensity score analysis
43. Portal vein leiomyosarcoma: A rare case of hepatic hilar tumor with review of the literature
44. Impact of age over 75 years on outcomes after pancreaticoduodenectomy
45. Comparison of alternative arterial anastomosis site during liver transplantation when the recipient’s hepatic artery is unusable
46. Prolonged dual hypothermic oxygenated machine preservation (DHOPE-PRO) in liver transplantation: study protocol for a stage 2, prospective, dual-arm, safety and feasibility clinical trial
47. Influence of the ABO Blood Group System on Hepatocellular Carcinoma Recurrence After Liver Transplantation
48. Oxygenated versus non‐oxygenated flush out and storage of donor livers – an experimental study
49. DONATION AFTER CIRCULATORY DEATH LIVERS CAN BE SAFELY USED FOR TRANSPLANTATION IN PATIENTS WITH PRE-EXISTING PORTAL VEIN THROMBOSIS
50. THERAPEUTIC ANTICOAGULATION IN PREVENTION OF RECURRENT PORTAL VEIN THROMBOSIS AFTER LIVER TRANSPLANTATION: UTILITY OR FUTILITY?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.